Bivalirudin and Brilinta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bivalirudin (bivalirudin) and Brilinta (ticagrelor). Common drug interactions include subarachnoid haemorrhage among females and acute myocardial infarction among males.

The phase IV clinical study analyzes what interactions people have when they take Bivalirudin and Brilinta. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Bivalirudin?

Bivalirudin has active ingredients of bivalirudin. eHealthMe is studying from 908 Bivalirudin users. Check the latest studies of Bivalirudin.

What is Brilinta?

Brilinta has active ingredients of ticagrelor. It is often used in stent. eHealthMe is studying from 22,469 Brilinta users. Check the latest studies of Brilinta.

On Jul, 04, 2026

14 people who take Bivalirudin and Brilinta together, and have interactions are studied.

Bivalirudin and Brilinta drug interactions.

What are the common drug interactions of Bivalirudin and Brilinta, by gender? *:

female:

Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)

male:

Acute myocardial infarction (acute heart attack)
Thrombosis (formation of a blood clot inside a blood vessel)
Electrocardiogram st segment elevation
Nephropathy (damage to or disease of a kidney)
Nephropathy toxic (damage to kidney due to toxins)
Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
Renal failure acute (rapid kidney dysfunction)
Renal tubular necrosis (death of kidney tubules)
Ventricular asystole (cardiac arrest rhythm in which there is no discernible electrical activity on the ecg monitor)
Vomiting

What are the common drug interactions of Bivalirudin and Brilinta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Vomiting

40-49:

n/a

50-59:

Acute myocardial infarction (acute heart attack)
Coronary artery thrombosis (clot formation in coronary artery)

60+:

Acute myocardial infarction (acute heart attack)
Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)
Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
Renal failure acute (rapid kidney dysfunction)
Renal tubular necrosis (death of kidney tubules)
Thrombosis (formation of a blood clot inside a blood vessel)
Ventricular asystole (cardiac arrest rhythm in which there is no discernible electrical activity on the ecg monitor)
Acute respiratory distress syndrome
Atrioventricular block (heart block)
Atrioventricular block complete (heart block complete)

What are the existing conditions these people have? *

Percutaneous Coronary Intervention: 6 people, 42.86%
Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 5 people, 35.71%
Electrocardiogram St Segment Elevation: 1 person, 7.14%
Coal Worker's Pneumoconiosis (lung disease of coal worker affects upper part of lung): 1 person, 7.14%
Acute Myocardial Infarction (acute heart attack): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Bivalirudin and Brilinta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously